From Proteome Analysis to individualized medicine - New ways for diagnostics and therapy in rheumatoid arthritis;Von der Proteom-analyze zur individualisierten medizin - Neue diagnose- und therapieansatze fur die rheumatoide arthritis

Klinikarzt

Volumn 29, Issue 8-9, 2000, Pages 206-211

  Kekow, J ^a   Glocker, M O ^a   Thiesen, H J ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Autoimmune diseases; Evidence based individualized medicine (EBIM); Proteomics; RA Chips; Rheumatoid arthritis (RA); RNA Profiling

Indexed keywords

PROTEOME;

ARTICLE; AUTOIMMUNE DISEASE; DATA ANALYSIS; DIAGNOSTIC VALUE; GENE EXPRESSION; GENETIC SUSCEPTIBILITY; GENOME; PREDICTION; RHEUMATOID ARTHRITIS;

EID: 0033835507     PISSN: 03412350     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Disease severity in rheumatoid arthritis: Relationships of plasma tumor necrosis factor-alpha, soluble interleukin2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures
2. Antibodies to tumor necrosis factor alpha as treatment for Crohn's disease
3. Proteomics: Quantitative and physical mapping of cellular proteins
4. The future role of anti-tumor necrosis factor (TNF) products in the treatment of rheumatoid arthritis
5. Mapping autoimmunity genes
6. The current state of two-dimensional electrophoresis with immobilized pH gradients
7. Genetic linkage analysis of collagen-induced arthritis in the mouse
8. Atiopathogenese der rheumatoiden Arthritis
9. Multi-functional role of proteases in rheumatic diseases
10. Rheumatologie im nachsten Jahrtausend: Verzicht auf Cortison? Arthritis und Rheuma
11. Proteome analysis: A pathway to the functional analysis of proteins
12. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc Fusion Protein
13. Interleukin I and tumor necrosis factor stimulate vascular endothelial cells to promote transendothelial neutrophil passage
14. Anticytokine therapy - A new era in the treatment of rheumatoid arthritis?
15. Genetic epidemiology of rheumatoid disease
16. Is rheumatoid arthritis a disappearing disease?
17. A trial of etanercept, a recombinant tumor nekrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate
18. An assessment of the annual and long-term direct costs of rheumatoid arthritis: The impact of poor function and functional decline